In partnership with

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today's edition is sponsored by Kalshi, the regulated prediction market where operators, lawyers, and policy professionals can trade on the events that actually move this industry.

Curaleaf told the market yesterday that it believes rescheduling is close enough to justify cleaning up its capital structure for a U.S. exchange uplisting. Rhode Island, after a year of licensing turbulence, picked the person who built the program to run it, and a legislative fix moved into the General Assembly the same week. Delaware is staring at a federal hemp clock without agreement on which channel sells the same intoxicating molecule. Illinois wants to route at least part of the hemp market through its cannabis system. The VA opened a randomized MDMA trial. The picture is of an industry that has spent the last month moving from rescheduling announcement into rescheduling implementation, and a federal hemp deadline pulling state legislatures, retailers, and capital markets along with it.

🪙 Curaleaf prepares for the boards.
🪑 Rhode Island picks its chair, files its fix.
🧠 VA puts MDMA back in a trial.

The whole modern world has divided itself into Conservatives and Progressives. The business of Progressives is to go on making mistakes. The business of Conservatives is to prevent the mistakes from being corrected.

G.K. Chesterton

The LA Mayor Market Ends June 2. The Odds Are Moving Now.

Karen Bass is at 68%. Spencer Pratt at 27%. Over $21 million is already trading on the Los Angeles Mayor race on Kalshi — and the prices are shifting every day as local news breaks. The window to get in before the consensus hardens is closing. The best prediction market trades happen before everyone agrees on the outcome. That moment is right now, before June 2. Peer-to-peer, no house, cash out anytime. Trade $10, get $10 free to start.

Trade responsibly.

Subscribe to keep reading

This content is free, but you must be subscribed to Policy, Decoded to continue reading.

Already a subscriber?Sign in.Not now

Recommended for you